Treatment Guidelines in Rheumatoid Arthritis-Optimizing the Best of Both Worlds

被引:2
|
作者
Jagpal, Aprajita [1 ]
Singh, Jasvinder A. [1 ,2 ,3 ]
机构
[1] Univ Alabama Birmingham, Div Rheumatol, 510 20th St S Off 836, Birmingham, AL 35233 USA
[2] Birmingham VA Med Ctr, Birmingham, AL USA
[3] UAB Sch Publ Hlth, Dept Epidemiol, 1665 Univ Blvd,Ryals Publ Hlth Bldg,Room 220, Birmingham, AL 35294 USA
关键词
Rheumatoid arthritis; Treatment guidelines; DOUBLE-BLIND; DISEASE-ACTIVITY; CERTOLIZUMAB PEGOL; TRIPLE THERAPY; COMBINATION THERAPY; PLUS METHOTREXATE; ETANERCEPT; REMISSION; DRUG; RISK;
D O I
10.1007/s40674-020-00163-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of reviewRheumatoid arthritis (RA) leads to significant joint damage and systemic complications. Available treatment options for RA has made it possible to achieve a good control over disease activity and improve patient outcomes. In this review, we discuss management guidelines for RA and their practical application by discussing clinical scenarios commonly encountered in rheumatology practice.Recent findingsEuropean League Against Rheumatism recently updated treatment recommendations for management of RA. The general fundamentals of these recommendations are similar to those of the 2015 American College of Rheumatology guidelines for the treatment of RA but with some key distinctions. We discuss three RA cases to illustrate key aspects of treatment guidelines. New data show increased cardiovascular risk in patients with RA that is possibly related to associated systemic inflammation.SummaryWhile several questions about RA remain unanswered, the clinical outcomes have improved in recent years. A strategic approach to manage RA is recommended which involves early diagnosis and treatment and escalating treatments to achieve a therapeutic target. In addition to treating RA disease activity, management of comorbid conditions is imperative to prevent long-term systemic damage.
引用
收藏
页码:354 / 369
页数:16
相关论文
共 50 条
  • [1] Treatment Guidelines in Rheumatoid Arthritis—Optimizing the Best of Both Worlds
    Aprajita Jagpal
    Jasvinder A. Singh
    Current Treatment Options in Rheumatology, 2020, 6 : 354 - 369
  • [2] The BeSt story: on strategy trials in rheumatoid arthritis
    Klarenbeek, Naomi B.
    Allaart, Cornelia F.
    Kerstens, Pit J. S. M.
    Huizinga, Tom W. J.
    Dijkmans, Ben A. C.
    CURRENT OPINION IN RHEUMATOLOGY, 2009, 21 (03) : 291 - 298
  • [3] Treatment Guidelines in Rheumatoid Arthritis
    Singh, Jasvinder A.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2022, 48 (03) : 679 - 689
  • [4] Update of the Guidelines for the Pharmacological Treatment of Rheumatoid Arthritis by the Mexican College of Rheumatology 2023
    Abud-Mendoza, Carlos
    Aceves-Avila, Francisco Javier
    Arce-Salinas, Cesar Alejandro
    Nemegyei, Jose Alvarez
    Barile-Fabris, Leonor
    Duran-Barragan, Sergio
    Flores-Alvarado, Diana Elsa
    Hernandez-Nunez, Eufrates
    Irazoque-Palazuelos, Fedra
    Moctezuma-Rios, Jose Francisco
    Pascual-Ramos, Virginia
    Portela-Hernandez, Margarita
    Silveira, Luis Humberto
    Andrade-Ortega, Lilia
    Barrera-Vargas, Ana
    Carrillo-Vazquez, Sandra
    Castro-Colin, Zully
    Cuevas-Orta, Enrique
    Flores-Suarez, Luisfelipe
    Guaracha-Basanez, Guillermo Arturo
    Hernandez-Cabrera, Maria Fernanda
    Hernandez-Galarza, Ivan de Jesus
    Herrera-vanOostdam, David Alejandro
    Lobato-Belmonte, Adriana Concepcion
    Martinez-Martinez, Lauraaline
    Martinez-Martinez, Marcoulises
    Medrano-Ramirez, Gabriel
    Merayo-Chalico, Francisco Javier
    Meza-Lopez y Olguin, Graciela
    Olan, Francisco
    Pena-Santos, Genaro
    Ramos-Remus, Cesar
    Reyes-Cordero, Greta
    Rivera-Teran, Vijaya
    Rojas-Serrano, Jorge
    Serna-Pena, Griselda
    Sicsik-Ayala, Sandra
    Sifuentes-Cantu, Cesar Armando
    Vega-Morales, David
    Villasenor-Ovies, Pablo
    Xibille-Friedmann, Daniel
    Pacheco-Tena, Cesar
    REUMATOLOGIA CLINICA, 2024, 20 (05): : 263 - 280
  • [5] BeSt practice: the success of early-targeted treatment in rheumatoid arthritis
    van den Broek, M.
    Lems, W. F.
    Allaart, C. F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : S35 - S38
  • [6] Adalimumab in the treatment of rheumatoid arthritis
    Voulgari, Paraskevi V.
    Kaltsonoudis, Evripidis
    Papagoras, Charalampos
    Drosos, Alexandros A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (12) : 1679 - 1686
  • [7] Etanercept for the treatment of rheumatoid arthritis
    Zhao, Sizheng
    Mysler, Eduardo
    Moots, Robert J.
    IMMUNOTHERAPY, 2018, 10 (06) : 433 - 445
  • [8] Optimizing Rheumatoid Arthritis Patients for Surgery
    Sigmund, Alana
    Russell, Linda A.
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (08)
  • [9] Predicting best treatment in rheumatoid arthritis
    Lewis, Myles J.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 64
  • [10] Egyptian guidelines for the treatment of Rheumatoid Arthritis — 2022 update
    Yasser El Miedany
    Mohammed Hassan Abu-Zaid
    Maha El Gaafary
    Mona Mansour
    Nihal Fathy
    Waleed Hassan
    Mohamed Mortada
    Mervat Eissa
    Samar Abdelhamed Tabra
    Salwa Galal
    Nermeen Foad
    Rehab Ali Ibrahim
    Basma Medhat
    Gehan El Olemy
    Yasmin Adel
    Rasha Ghaleb
    Sally Saber
    Naglaa GadAllah
    Egyptian Rheumatology and Rehabilitation, 2022, 49